Skip to main content
. Author manuscript; available in PMC: 2019 Mar 18.
Published in final edited form as: Toxicol Appl Pharmacol. 2018 Jun 19;355:28–42. doi: 10.1016/j.taap.2018.06.001

Table 3.

Functional annotation of significantly modulated protein expression in the IC following H2S exposure at 2h, days 2, and 4. Table displays dysregulated molecular pathways and total number of proteins associated with GO-term definition. Note the similarity in pathways at 2 h and on day 2.

ID Name #Gene FDR
2h
P00041 Metabotropic glutamate receptor group I pathway 2 5.31E-01
P02772 Pyruvate metabolism 1 1.00E + 00
P00019 Endothelin signaling pathway 2 1.00E + 00
P02746 Heme biosynthesis 1 1.00E + 00
P00031 Inflammation mediated by chemokine and cytokine signaling pathway 3 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 3 1.00E + 00
P00024 Glycolysis 1 1.00E + 00
P04386 Histamine H2 receptor mediated signaling pathway 1 1.00E + 00
P05913 Enkephalin release 1 1.00E + 00
P00017 DNA replication 1 1.00E + 00
Day 2
P00041 Metabotropic glutamate receptor group I pathway 2 5.79E-01
P00017 DNA replication 2 5.79E-01
P02772 Pyruvate metabolism 1 1.00E + 00
P02746 Heme biosynthesis 1 1.00E + 00
P00019 Endothelin signaling pathway 2 1.00E + 00
P00031 Inflammation mediated by chemokine and cytokine signaling pathway 3 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 3 1.00E + 00
P00024 Glycolysis 1 1.00E + 00
P04386 Histamine H2 receptor mediated signaling pathway 1 1.00E + 00
P05913 Enkephalin release 1 1.00E + 00
Day 4
P00029 Huntington disease 2 1.00E + 00
P00020 FAS signaling pathway 1 1.00E + 00
P06664 Gonadotropin-releasing hormone receptor pathway 2 1.00E + 00
P00016 Cytoskeletal regulation by Rho GTPase 1 1.00E + 00